Your browser doesn't support javascript.
Successful treatment of a centenarian with coronavirus disease 2019 (COVID-19) using convalescent plasma.
Kong, Yujie; Cai, Chen; Ling, Li; Zeng, Li; Wu, Meihong; Wu, Yanyun; Zhang, Wei; Liu, Zhong.
  • Kong Y; Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, 610052, Chengdu, Sichuan Province, PR China; Key laboratory of transfusion adverse reactions, CAMS, 610052, Chengdu, Sichuan Province, PR China.
  • Cai C; Department of Special Clinic, First affiliated hospital, the Second Military Medical University, Shanghai, 200433, Shanghai, PR China; Guanggu District, the Maternal and Child Health Hospital of Hubei Province, 430070, Wuhan, Hubei Province, PR China.
  • Ling L; Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, 610052, Chengdu, Sichuan Province, PR China; Key laboratory of transfusion adverse reactions, CAMS, 610052, Chengdu, Sichuan Province, PR China.
  • Zeng L; Guanggu District, the Maternal and Child Health Hospital of Hubei Province, 430070, Wuhan, Hubei Province, PR China; Department of Organ Transplantation, First affiliated hospital, the Second Military Medical University, Shanghai, 200433, Shanghai, PR China.
  • Wu M; Guanggu District, the Maternal and Child Health Hospital of Hubei Province, 430070, Wuhan, Hubei Province, PR China; Department of oncology, First affiliated hospital, the Second Military Medical University, Shanghai, 200433, Shanghai, PR China.
  • Wu Y; University of Miami, Miami, Florida, United States.
  • Zhang W; Guanggu District, the Maternal and Child Health Hospital of Hubei Province, 430070, Wuhan, Hubei Province, PR China; Department of Respiratory and Critical Care Medicine, First affiliated hospital, the Second Military Medical University, Shanghai, 200433, Shanghai, PR China. Electronic address: zhan
  • Liu Z; Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, 610052, Chengdu, Sichuan Province, PR China; Key laboratory of transfusion adverse reactions, CAMS, 610052, Chengdu, Sichuan Province, PR China. Electronic addr
Transfus Apher Sci ; 59(5): 102820, 2020 Oct.
Article in English | MEDLINE | ID: covidwho-398907
ABSTRACT

BACKGROUND:

Because treatment options for coronavirus disease 2019 (COVID-19) are very limited, the use of convalescent plasma has bee explored. CASE PRESENTATION AND TREATMENT A male centenarian with cough and dyspnea for 2 months was diagnosed with COVID-19. Without effective treatments and with the increased risks of antiviral therapy for the elderly, this patient was given convalescent plasma. The viral load, complete blood count, inflammatory indicators, vital signs, and clinical symptoms were observed before and after COVID-19 convalescent plasma transfusion.

RESULTS:

After convalescent plasma transfusion, significant improvement was observed on laboratory indicators and clinical symptoms of the patient. Concurrently, SARS-CoV-2 viral load decreased sharply after the first transfusion (from 2.55 × 104 to 1.39 × 103 copies/mL) and became undetectable after the second transfusion.

CONCLUSIONS:

With the substantial increase of COVID-19 in recent months,treatment for elderly patients has become restricted in some countries. The successful treatment of this 100-year-old patient using convalescent plasma suggests that we should consider adding convalescent plasma in th management of the elderly.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Case report / Experimental Studies / Prognostic study Limits: Humans / Male Language: English Journal: Transfus Apher Sci Journal subject: Hematology Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Case report / Experimental Studies / Prognostic study Limits: Humans / Male Language: English Journal: Transfus Apher Sci Journal subject: Hematology Year: 2020 Document Type: Article